Hagerman RJ, Hagerman PJ: The fragile X premutation: into the phenotypic fold. Curr Opin Genet Dev. 2002, 12: 278-283. 10.1016/S0959-437X(02)00299-X.
Article
CAS
PubMed
Google Scholar
Wisniewski KE, Segan SM, Miezejeski CM, Sersen EA, Rudelli RD: The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet. 1991, 38: 476-480. 10.1002/ajmg.1320380267.
Article
CAS
PubMed
Google Scholar
Kooy RF, D'Hooge R, Reyniers E, Bakker CE, Nagels G, De Boulle K, Storm K, Clincke G, De Deyn PP, Oostra BA, Willems PJ: Transgenic mouse model for the fragile X syndrome. Am J Med Genet. 1996, 64: 241-245. 10.1002/(SICI)1096-8628(19960809)64:2<241::AID-AJMG1>3.0.CO;2-X.
Article
CAS
PubMed
Google Scholar
Bakker CE, Verheij C, Willemsen R, Vanderhelm R, Oerlemans F, Vermey M, Bygrave A, Hoogeveen AT, Oostra BA, Reyniers E: Fmr1 knockout mice: a model to study fragile X mental retardation. Cell. 1994, 78: 23-33.
Google Scholar
Musumeci SA, Bosco P, Calabrese G, Bakker C, De Sarro GB, Elia M, Ferri R, Oostra BA: Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia. 2000, 41: 19-23. 10.1111/j.1528-1157.2000.tb01499.x.
Article
CAS
PubMed
Google Scholar
Chen L, Toth M: Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience. 2001, 103: 1043-1050. 10.1016/S0306-4522(01)00036-7.
Article
CAS
PubMed
Google Scholar
Yan QJ, Asafo-Adjei PK, Arnold HM, Brown RE, Bauchwitz RP: A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse. Genes Brain Behav. 2004, 3: 337-359. 10.1111/j.1601-183X.2004.00087.x.
Article
CAS
PubMed
Google Scholar
El Idrissi A, Ding XH, Scalia J, Trenkner E, Brown WT, Dobkin C: Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse. Neurosci Lett. 2005, 377: 141-146. 10.1016/j.neulet.2004.11.087.
Article
CAS
PubMed
Google Scholar
Riback CE, Lauterborn JC, Navetta MS, Gall CM: The inferior colliculus of GEPRs contains greater numbers of cells that express glutamate decarboxylase (GAD67) mRNA. Epilepsy Res. 1993, 14: 105-113. 10.1016/0920-1211(93)90015-Y.
Article
Google Scholar
El Idrissi A: Taurine and brain excitability. Adv Exp Med Biol. 2006, 583: 315-322. full_text.
Article
CAS
PubMed
Google Scholar
El Idrissi A: Taurine increases mitochondrial buffering of calcium: role in neuroprotection. Amino Acids. 2006
Google Scholar
El Idrissi A, Messing J, Scalia J, Trenkner E: Prevention of epileptic seizures by taurine. Adv Exp Med Biol. 2003, 526: 515-525.
Article
CAS
PubMed
Google Scholar
Foos TM, Wu JY: The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis. Neurochemical Research. 2002, 27: 21-26. 10.1023/A:1014890219513.
Article
CAS
PubMed
Google Scholar
Lombardini JB: Effects of taurine on calcium ion uptake and protein phosphorylation in rat retinal membrane preparations. J Neurochem. 1985, 45: 268-275. 10.1111/j.1471-4159.1985.tb05503.x.
Article
CAS
PubMed
Google Scholar
Saransaari P, Oja SS: Taurine and neural cell damage. Amino Acids. 2000, 19: 509-526. 10.1007/s007260070003.
Article
CAS
PubMed
Google Scholar
Schaffer S, Solodushko V, Azuma J: Taurine-deficient cardiomyopathy: role of phospholipids, calcium and osmotic stress. Adv Exp Med Biol. 2000, 483: 57-69. full_text.
Article
CAS
PubMed
Google Scholar
Solis JM, Herranz AS, Herreras O, Lerma J, Martin del Rio R: Does taurine act as an osmoregulatory substance in the rat brain?. Neurosci Lett. 1988, 91: 53-58. 10.1016/0304-3940(88)90248-0.
Article
CAS
PubMed
Google Scholar
El Idrissi A, Trenkner E: Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J Neurosci. 1999, 19: 9459-9468.
CAS
PubMed
Google Scholar
El Idrissi A, Trenkner E: Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochem Res. 2004, 29: 189-197. 10.1023/B:NERE.0000010448.17740.6e.
Article
CAS
PubMed
Google Scholar
Militante JD, Lombardini JB: Pharmacological characterization of the effects of taurine on calcium uptake in the rat retina. Amino Acids. 1998, 15: 99-108. 10.1007/BF01345283.
Article
CAS
PubMed
Google Scholar
Huxtable RJ: Physiological actions of taurine. Physiol Rev. 1992, 72: 101-163.
CAS
PubMed
Google Scholar
Lourenco R, Camilo ME: Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutr Hosp. 2002, 17: 262-270.
CAS
PubMed
Google Scholar
Boujendar S, Arany E, Hill D, Remacle C, Reusens B: Taurine supplementation of a low protein diet fed to rat dams normalizes the vascularization of the fetal endocrine pancreas. J Nutr. 2003, 133: 2820-2825.
CAS
PubMed
Google Scholar
Cherif H, Reusens B, Ahn MT, Hoet JJ, Remacle C: Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low-protein diet. J Endocrinol. 1998, 159: 341-348. 10.1677/joe.0.1590341.
Article
CAS
PubMed
Google Scholar
Dahri S, Snoeck A, Reusens-Billen B, Remacle C, Hoet JJ: Islet function in offspring of mothers on low-protein diet during gestation. Diabetes. 1991, 40 (Suppl 2): 115-120.
Article
CAS
PubMed
Google Scholar
Merezak S, Hardikar AA, Yajnik CS, Remacle C, Reusens B: Intrauterine low protein diet increases fetal beta-cell sensitivity to NO and IL-1 beta: the protective role of taurine. J Endocrinol. 2001, 171: 299-308. 10.1677/joe.0.1710299.
Article
CAS
PubMed
Google Scholar
Arany E, Strutt B, Romanus P, Remacle C, Reusens B, Hill DJ: Taurine supplement in early life altered islet morphology, decreased insulitis and delayed the onset of diabetes in non-obese diabetic mice. Diabetologia. 2004, 47: 1831-1837. 10.1007/s00125-004-1535-z.
Article
CAS
PubMed
Google Scholar
Franconi F, Loizzo A, Ghirlanda G, Seghieri G: Taurine supplementation and diabetes mellitus. Curr Opin Clin Nutr Metab Care. 2006, 9: 32-36. 10.1097/01.mco.0000196141.65362.46.
Article
CAS
PubMed
Google Scholar
Hansen SH: The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev. 2001, 17: 330-346. 10.1002/dmrr.229.
Article
CAS
PubMed
Google Scholar
Nandhini AT, Anuradha CV: Taurine modulates kallikrein activity and glucose metabolism in insulin resistant rats. Amino Acids. 2002, 22: 27-38. 10.1007/s726-002-8199-3.
Article
CAS
PubMed
Google Scholar
Petrik J, Arany E, McDonald TJ, Hill DJ: Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology. 1998, 139: 2994-3004. 10.1210/en.139.6.2994.
CAS
PubMed
Google Scholar
Liu Y, Tonna-DeMasi M, Park E, Schuller-Levis G, Quinn MR: Taurine chloramine inhibits production of nitric oxide and prostaglandin E2 in activated C6 glioma cells by suppressing inducible nitric oxide synthase and cyclooxygenase-2 expression. Brain Res Mol Brain Res. 1998, 59: 189-195. 10.1016/S0169-328X(98)00145-4.
Article
CAS
PubMed
Google Scholar
Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S: Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology. 1997, 138: 1736-1741. 10.1210/en.138.4.1736.
CAS
PubMed
Google Scholar
El Idrissi A: Taurine improves learning and retention in aged mice. Neurosci Lett. 2008, 436: 19-22. 10.1016/j.neulet.2008.02.070.
Article
CAS
PubMed
Google Scholar